Markets were crushed to start out the week as concerns about solvency for a major Chinese lender have gained traction. Many analysts and strategists are calling this the correction markets have been due for after a particularly hot summer. ARK Funds like the markets took a beating on Monday. ARKX performed the best out of the group, down 2.0% on the day, while ARKK underperformed the rest of the group, down 4.3%. The gains from last year are slowly sliding away, but Cathie Wood may have something up her sleeve as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major Buys that ARK Invest executed on September 20, 2021. Also check out all the ARK Invest sales that took place on that day.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here are some purchases we would highlight in this fund: 99,460 shares of UiPath, 29,357 shares of Coinbase, & 61,263 share of Robinhood.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. Some of the biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable purchases in this fund: 43,400 shares of Beam, 92,253 shares of Personalis, & 284,700 shares of Somalogic.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable purchases in this fund: 54,479 shares of Zoom, 202,238 shares of Signify Health, 43,679 shares of Roku, & 342,257 shares of Robinhood.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. More big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are a few purchases of note in this fund: 79,891 shares of Kratos & 147,987 shares of Markforged.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. There are some similar names in this fund as the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are a couple of notable purchases in this fund: 3,543 shares of Zillow & 198,058 shares of Vuzix.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Purchases worth noting in this fund: 37,022 shares of Blade Air Mobility.
Check out all the purchases here:
| FUND | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKF | Buy | PATH | UIPATH INC | 99,460 |
| ARKF | Buy | COIN | COINBASE GLOBAL INC | 29,357 |
| ARKF | Buy | HOOD | ROBINHOOD MARKETS INC | 61,263 |
| ARKG | Buy | BEAM | BEAM THERAPEUTICS INC | 43,400 |
| ARKG | Buy | PSNL | PERSONALIS INC | 92,253 |
| ARKG | Buy | SLGC | SOMALOGIC INC | 284,700 |
| ARKK | Buy | ZM | ZOOM VIDEO COMMUNICATIONS INC | 54,479 |
| ARKK | Buy | SGFY | SIGNIFY HEALTH INC | 202,238 |
| ARKK | Buy | ROKU | ROKU INC | 43,679 |
| ARKK | Buy | PD | PAGERDUTY INC | 90,130 |
| ARKK | Buy | PATH | UIPATH INC | 286,110 |
| ARKK | Buy | NVTA | INVITAE CORP | 340,808 |
| ARKK | Buy | COIN | COINBASE GLOBAL INC | 66,894 |
| ARKK | Buy | HOOD | ROBINHOOD MARKETS INC | 342,757 |
| ARKK | Buy | DNA | GINKGO BIOWORKS HOLDINGS INC | 589,921 |
| ARKQ | Buy | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS INC | 79,891 |
| ARKQ | Buy | MKFG | MARKFORGED HOLDING CORP | 147,987 |
| ARKW | Buy | Z | ZILLOW GROUP INC | 3,543 |
| ARKW | Buy | VUZI | VUZIX CORP | 198,058 |
| ARKX | Buy | ACHR | ARCHER AVIATION INC | 194,858 |
| ARKX | Buy | BLDE | BLADE AIR MOBILITY INC | 37,022 |
| ARKX | Buy | PATH | UIPATH INC | 21,441 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
